Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Phase 3

• Conditions: Neovascular Age-Related Macular Degeneration

• Registration Number: NCT00370539
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-08-30
• Study First Submitted QC: 2006-08-30
• Study First Posted: 2006-08-31
• Study Start: 2006-09
• Status Verified: 2006-11
• Study Completion: 2006-11
• Last Update Submitted: 2006-11-13
• Last Update Posted: 2006-11-14

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Cases of active neovascular AMD with visual acuity of 20/400- 20/40

Exclusion Criteria

• History of glaucoma or ocular hypertension
• Disciform scar

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Visual acuity

Secondary Outcome Measures

Name	Time	Method
Central macular thickness
Leakage in fluorescein angiography
Intraocular pressure
Anterior chamber reaction

Trial Locations

Locations (1)

Hamid Ahmadieh, MD; 🇮🇷 Tehran, Iran, Islamic Republic of